Esperion Releases Top Line Results For First Pivotal Phase 3 Study

Esperion announced positive results for the first in a series of pivotal phase 3 studies of its cholesterol lowering drug.

from Forbes Real Time https://www.forbes.com/sites/larryhusten/2018/03/07/esperion-releases-top-line-result-for-first-pivotal-phase-3-study/
via IFTTT